Fig 1.
Flow diagram illustrating the construction of the population of individuals with incident atherosclerotic cardiovascular disease (ASCVD) and low-density lipoprotein cholesterol (LDL-C) ≥1.8 mmol/L (equivalent to 70 mg/dL) (January 1, 2010 to December 31, 2015) based on data from nation-wide population registers and a laboratory database.
CPR, unique personal identification number.
Table 1.
Sociodemographic and clinical baseline characteristics of individuals (N = 11,997) at date of the incident atherosclerotic cardiovascular disease (ASCVD population) stratified by low-density lipoprotein cholesterol (LDL-C) ≥1.8 mmol/L (70 mg/dL) either during or before ASCVD hospitalization given by number and percentage (N, %) if nothing else is indicated.
Percentages are given by rows, except for Total where percentages are given within the column.
Fig 2.
Development of LDL-C goal achievement in the ASCVD population during the study period (1 January 2010–31 December 2015) given as proportion of individuals who reach treatment goals (LDL-C<1.8 mmol/L, equivalent to 70 mg/dL) within 1–180, 181–365 and 366–730 days after discharge, N = 15,193 individuals.
Fig 3.
Development of LLT treatment patterns in the ASCVD population during the study period (1 January 2010–31 December 2015) given as proportion of individuals who initiated treatment with (A) LLT and (B) intensive LLT before admission, from admission to 90 days after discharge, during 91–180 days after discharge and during 181–365 days after discharge, N = 11,997 individuals with an incident ASCVD.
Fig 4.
Development of progressively more intensive LLT treatment in the ASCVD population during the study period (1 January 2010–31 December 2015) given as proportion of individuals (A) 180 days before admission with incident ASCVD to 90 days after discharge, (B) 91–180 days and (C) 181–365 days after discharge, N = 11,997 individuals with an incident ASCVD.